The Effect of "Eye Drop Guide" on the Success Rate of Eye Drops Self-instillation in Glaucoma Patients

NCT ID: NCT01704248

Last Updated: 2012-10-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-10-31

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate if the Eye Drop Guide more effective than carefully instructed routine technique for chronic glaucoma patients to self-instill eye drops.

And what factors are associated with the failure of self-instillation eye drops with the Eye Drop Guide?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The participants are randomized into 2 groups. For group I; the participants will be instructed to use the Eye Drop Guide first while for group II; the participants will be instructed to use the routine self-instillation technique first. The instruction will be given to all participants by the same investigator. The participants are allowed to practice until confidence in the techniques to which they are assigned. The participants then are instructed to use only that technique to instill eye drops in both eyes every day and keep the diary to document the date, time of practice, and number of bottles use in each eye for practice at home. The investigators make a telephone visit at 1 week to remind the practice routine and the follow up schedule. The 2 week follow up will be scheduled to evaluate the self-instillation performance using the techniques to which they are assigned by the VDO recordings under the same setting as Day 1.

After VDO recordings the participants will be switched to receive the other technique with the same instruction as the other group. Allow the same period of practice in the hospital and at home. The investigators again will make a 1-week telephone visit and 2-week follow up after self-practice at home. At week 4 the VDO recordings of self-instillation performance will be taken again under the same setting as previous records.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eye Drops Self-instillation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

eye drops self-instillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Routine self-instillation technique

The participants first use the Routine self-instillation technique for two weeks and then switch to the Eye Drop Guide technique for another two weeks.

Group Type PLACEBO_COMPARATOR

Eye Drop Guide technique

Intervention Type DEVICE

1. Wash the hands.
2. Shake and then uncap the bottle.
3. Hold the bottle between the thumb, index, and/or middle finger of the dominant hand.
4. Use the lower lip of the cup to pull the lower lid down like what they normally do with the fingers.
5. Then place the upper lip down to cover the whole orbital rim area.
6. Tilt the head back if seated or standing.
7. Insert the bottle in the device all the way. Hold the bottle gently.
8. Look upward.
9. Squeeze the bottle one drop at a time until feel one drop instilled into the eye.
10. Close the eye 2-3 minutes.

For the non-seeing eye (best-corrected visual acuity ≤ 20/400) the participants should insert the bottle in the device before cover the eye then proceed with head tilt and look upward.

Eye Drop Guide technique

The participants first use the Eye Drop Guide technique for two weeks and then switch to the Routine self-instillation technique for another two weeks.

Group Type EXPERIMENTAL

Routine self-instillation technique

Intervention Type BEHAVIORAL

1. Wash the hands.
2. Shake and then uncap the bottle.
3. Hold the bottle between the thumb, index, and/or middle finger of the dominant hand.
4. Lie down or tilt the head back if seated or standing.
5. Using the other hand, pull the lower lid down.
6. Hold the bottle over the eye and look up.
7. Squeeze the bottle one drop at a time until feel one drop instilled into the eye.
8. Close the eye 2-3 minutes.

For the participants using more than one medication after instilling one bottle the participants should wait 3-5 minutes between administering different medications in the same eye.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Eye Drop Guide technique

1. Wash the hands.
2. Shake and then uncap the bottle.
3. Hold the bottle between the thumb, index, and/or middle finger of the dominant hand.
4. Use the lower lip of the cup to pull the lower lid down like what they normally do with the fingers.
5. Then place the upper lip down to cover the whole orbital rim area.
6. Tilt the head back if seated or standing.
7. Insert the bottle in the device all the way. Hold the bottle gently.
8. Look upward.
9. Squeeze the bottle one drop at a time until feel one drop instilled into the eye.
10. Close the eye 2-3 minutes.

For the non-seeing eye (best-corrected visual acuity ≤ 20/400) the participants should insert the bottle in the device before cover the eye then proceed with head tilt and look upward.

Intervention Type DEVICE

Routine self-instillation technique

1. Wash the hands.
2. Shake and then uncap the bottle.
3. Hold the bottle between the thumb, index, and/or middle finger of the dominant hand.
4. Lie down or tilt the head back if seated or standing.
5. Using the other hand, pull the lower lid down.
6. Hold the bottle over the eye and look up.
7. Squeeze the bottle one drop at a time until feel one drop instilled into the eye.
8. Close the eye 2-3 minutes.

For the participants using more than one medication after instilling one bottle the participants should wait 3-5 minutes between administering different medications in the same eye.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have been diagnosed of chronic glaucoma for 3 months or longer
* Age of 18 years or over
* Self-administer eye drops regularly

Exclusion Criteria

* Perioperative patients
* Patients who were blind from other diseases
* Patients with ophthalmic conditions that affect the eye drop instillation e.g. nystagmus, ptosis, exophthalmos, enophthalmos, microphthalmos, symblepharon, restrictive ophthalmoplegia
* Patients whose underlying conditions would affect the patient's adherence to the protocol e.g. dementia, psychosis, mental retardation, neurological conditions resulting in tremor or paralysis, rheumatoid arthritis, hand deformities
* Patients who are allergic to artificial tears eye drop
* Patients who are not able to return for the follow-up schedule
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mahidol University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Darin Sakiyalak, MD

Role: PRINCIPAL_INVESTIGATOR

Mahidol University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Medicine, Siriraj Hospital, Mahidol University

Bangkok, , Thailand

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Darin Sakiyalak, MD

Role: CONTACT

Phone: 66204198033-4

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Darin Sakiyalak, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

440/2555 (EC4)

Identifier Type: -

Identifier Source: org_study_id